# FDA Inspection 1082416 - Cohance Lifesciences Limited - February 08, 2019

Source: https://www.keypedia.com/records/fda_inspections/cohance-lifesciences-limited/929cac66-0cc8-42a8-b1fe-6c8d95624a2a
Source feed: FDA_Inspections

> FDA Inspection 1082416 for Cohance Lifesciences Limited on February 08, 2019. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1082416
- Company Name: Cohance Lifesciences Limited
- Inspection Date: 2019-02-08
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1265534 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/cohance-lifesciences-limited/114bc30d-1dd9-453c-bbbe-fecc27d00bfa)
- [FDA Inspection 1265534 - 2025-03-07](https://www.keypedia.com/records/fda_inspections/cohance-lifesciences-limited/aa011d0a-1c47-43e4-9184-f86140a33e17)
- [FDA Inspection 868591 - 2014-03-05](https://www.keypedia.com/records/fda_inspections/cohance-lifesciences-limited/1dc2b038-7927-4ea4-9f8d-ff2b8cf63a0b)

Company: https://www.keypedia.com/companies/cohance-lifesciences-limited/8e48a668-3018-4c94-b846-2cdd61205a18

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c